H. Henry Li - Concepedia

Author

H. Henry Li

Institute for Asthma and Allergy

Also Known As

H. Henry Li, Haipian LI, Hsiu-hua Li

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Institute for Asthma and Allergy University of California San Diego Penn State Milton S. Hershey Medical Center University of Cincinnati Icahn School of Medicine at Mount Sinai

About

H. Henry Li is an author at Institute for Asthma and Allergy specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	507
2	Emergency Medicine	2	2	76
3	Natural Sciences	1	1	34
4	Immunology	1	1	40
5	Pathology	1	1	40

H. Henry Li

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema Paula J. Busse, Sandra C. Christiansen, Marc A. Riedl, The Journal of Allergy and Clinical Immunology In Practice	2020	320
Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema Marco Cicardi, Robyn J. Levy, Donald McNeil, New England Journal of Medicine	2010	299
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein, JAMA	2018	273
Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial William R. Lumry, H. Henry Li, Robyn J. Levy, Annals of Allergy Asthma & Immunology ThrombosisCardiovascular DiseaseHereditary AngioedemaPharmacologyPlacebo-controlled Trial	2011	217
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis Aleena Banerji, Paula J. Busse, Mustafa M. Shennak, New England Journal of Medicine	2017	167
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial Bruce L. Zuraw, William R. Lumry, Douglas Johnston, Journal of Allergy and Clinical Immunology	2020	155
EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema Robyn J. Levy, William R. Lumry, Donald McNeil, Annals of Allergy Asthma & Immunology Subcutaneous Ecallantide TreatmentHereditary AngioedemaAngiologyDermatologyMedicine	2010	140
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema William R. Lumry, Timothy Craig, Bruce L. Zuraw, The Journal of Allergy and Clinical Immunology In Practice	2018	87
Consensus on treatment goals in hereditary angioedema: A global Delphi initiative Marcus Maurer, Emel Aygören‐Pürsün, Aleena Banerji, Journal of Allergy and Clinical Immunology	2021	61
Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies Albert L. Sheffer, Marilyn Campion, Robyn J. Levy, Journal of Allergy and Clinical Immunology Cardiovascular DiseaseAngiologyEmergency MedicineMedicineCardiology	2011	60

Page 1